We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Teams With Biocon To Market Biosimilars for Diabetes
Pfizer Teams With Biocon To Market Biosimilars for Diabetes
October 18, 2010
Diving into the biosimilars market, Pfizer inked a collaborative deal on Monday with India-based Biocon aimed at gaining an edge on the generics market for diabetes products that will expand after 2014 due to patent expirations.